These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 15909808
1. [Relevance of certain factors in the effectiveness of chemoradiotherapy for Hodgkin's disease]. Kanaev SV, Gershanovich ML, Pozharisskiĭ KM, Girshovich MM, Golovanov SG. Vopr Onkol; 2005; 51(1):56-9. PubMed ID: 15909808 [Abstract] [Full Text] [Related]
2. [Clinical evaluation of efficacy of chemoradiotherapy for Hodgkin's disease]. Kanaev SV, Gershanovich ML, Pozharisskiĭ KM, Girshovich MM, Malinin AP, Golovanov SG. Vopr Onkol; 2004; 50(6):652-7. PubMed ID: 15755057 [Abstract] [Full Text] [Related]
3. [Clinical evaluation of combined treatment of stage III(B) Hodgkin's disease]. Kanaev SV, Golovanov SG, Girshovich MM, Gershanovich ML. Vopr Onkol; 2006; 52(5):525-30. PubMed ID: 17168360 [Abstract] [Full Text] [Related]
4. [Is irradiation of intact ileoinguinal lymph nodes necessary in radiochemotherapy for stage-III Hodgkin's disease?]. Kanaev SV, Girshovich MM, Golovanov SG, Gershanovich ML. Vopr Onkol; 2007; 53(4):453-5. PubMed ID: 17969410 [Abstract] [Full Text] [Related]
5. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY. Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685 [Abstract] [Full Text] [Related]
8. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. Behringer K, Breuer K, Reineke T, May M, Nogova L, Klimm B, Schmitz T, Wildt L, Diehl V, Engert A, German Hodgkin's Lymphoma Study Group. J Clin Oncol; 2005 Oct 20; 23(30):7555-64. PubMed ID: 16234521 [Abstract] [Full Text] [Related]
9. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases]. Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ. Ai Zheng; 2007 Dec 20; 26(12):1360-4. PubMed ID: 18076802 [Abstract] [Full Text] [Related]
10. Hodgkin's disease: treatment with low dose radiation and chemotherapy. Donaldson SS. Front Radiat Ther Oncol; 1981 Dec 20; 16():122-33. PubMed ID: 7333475 [No Abstract] [Full Text] [Related]
13. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients. Akhtar S, El Weshi A, Abdelsalam M, Hussaini H, Janabi I, Rahal M, Maghfoor I. Bone Marrow Transplant; 2007 Oct 20; 40(7):651-8. PubMed ID: 17660837 [Abstract] [Full Text] [Related]
14. Interrelationship between several prognostic factors in Hodgkin's disease. Kotlarek-Haus S, Gabryś K, Starzyk H, Sciborski R, Gałazka Z. Arch Geschwulstforsch; 1982 Oct 20; 52(4):293-301. PubMed ID: 7138241 [Abstract] [Full Text] [Related]
19. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma]. Yang BY, Yong WB, Zhu J, Zheng W, Zhang YT, Wang XP, Meng SN. Zhonghua Zhong Liu Za Zhi; 2005 Mar 20; 27(3):174-6. PubMed ID: 15946571 [Abstract] [Full Text] [Related]